Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

NCT04774822 is registered in ClinicalTrials.gov with RETINA-AI Health, Inc. as lead sponsor.

NCT NCT04774822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04774822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device
Lead sponsor
RETINA-AI Health, Inc.
Phase
Observational
Overall status
Completed
Start date
March 25, 2021
Completion date
August 31, 2021
Enrollment
397 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic eye problems, diabetic macular edema, diabetic retinopathy